(Reuters) - The rulings by the U.S. District Court for the Southern District of New York represented the second wave of patent disputes over Prilosec.
In 2002, the court ruled that Andrx, Cheminor, and Genpharm had infringed AstraZeneca's patents, but that KUDCo/Schwarz Pharma had not.
Read more at Reuters.com Government Filings News
In 2002, the court ruled that Andrx, Cheminor, and Genpharm had infringed AstraZeneca's patents, but that KUDCo/Schwarz Pharma had not.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment